These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 21624363)
1. Heregulin activation of ErbB2/ErbB3 signaling potentiates the integrity of airway epithelial barrier. Gon Y; Matsumoto K; Terakado M; Sekiyama A; Maruoka S; Takeshita I; Kozu Y; Okayama Y; Ra C; Hashimoto S Exp Cell Res; 2011 Aug; 317(13):1947-53. PubMed ID: 21624363 [TBL] [Abstract][Full Text] [Related]
2. Induction or suppression of expression of cytochrome C oxidase subunit II by heregulin beta 1 in human mammary epithelial cells is dependent on the levels of ErbB2 expression. Sun Y; Lin H; Zhu Y; Ma C; Ye J; Luo J J Cell Physiol; 2002 Aug; 192(2):225-33. PubMed ID: 12115729 [TBL] [Abstract][Full Text] [Related]
3. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells. Ram TG; Hosick HL; Ethier SP J Cell Physiol; 2000 Jun; 183(3):301-13. PubMed ID: 10797304 [TBL] [Abstract][Full Text] [Related]
4. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides. Motoyama AB; Hynes NE; Lane HA Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928 [TBL] [Abstract][Full Text] [Related]
5. Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase. Tan M; Grijalva R; Yu D Cancer Res; 1999 Apr; 59(7):1620-5. PubMed ID: 10197638 [TBL] [Abstract][Full Text] [Related]
7. Interaction of integrin alpha(6)beta(4) with ErbB3 and implication in heregulin-induced ErbB3/ErbB2-mediated DNA synthesis. Kawano S; Mizutani K; Miyata M; Ikeda W; Takai Y Genes Cells; 2010 Sep; 15(9):995-1001. PubMed ID: 20695903 [TBL] [Abstract][Full Text] [Related]
8. MUC4 involvement in ErbB2/ErbB3 phosphorylation and signaling in response to airway cell mechanical injury. Theodoropoulos G; Carraway CA; Carraway KL J Cell Biochem; 2009 May; 107(1):112-22. PubMed ID: 19288496 [TBL] [Abstract][Full Text] [Related]
9. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification. Ram TG; Schelling ME; Hosick HL Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865 [TBL] [Abstract][Full Text] [Related]
10. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness. Lewis GD; Lofgren JA; McMurtrey AE; Nuijens A; Fendly BM; Bauer KD; Sliwkowski MX Cancer Res; 1996 Mar; 56(6):1457-65. PubMed ID: 8640840 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020 [TBL] [Abstract][Full Text] [Related]
12. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175. Schaefer G; Fitzpatrick VD; Sliwkowski MX Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014 [TBL] [Abstract][Full Text] [Related]
13. Interactions between progestins and heregulin (HRG) signaling pathways: HRG acts as mediator of progestins proliferative effects in mouse mammary adenocarcinomas. Balañá ME; Lupu R; Labriola L; Charreau EH; Elizalde PV Oncogene; 1999 Nov; 18(46):6370-9. PubMed ID: 10597237 [TBL] [Abstract][Full Text] [Related]
14. Differentiation of human airway epithelia is dependent on erbB2. Vermeer PD; Panko L; Karp P; Lee JH; Zabner J Am J Physiol Lung Cell Mol Physiol; 2006 Aug; 291(2):L175-80. PubMed ID: 16489114 [TBL] [Abstract][Full Text] [Related]
15. Analysis of heregulin-induced ErbB2 phosphorylation with a high-throughput Kinase receptor activation enzyme-linked immunosorbant assay. Sadick MD; Sliwkowski MX; Nuijens A; Bald L; Chiang N; Lofgren JA; Wong WL Anal Biochem; 1996 Mar; 235(2):207-14. PubMed ID: 8833330 [TBL] [Abstract][Full Text] [Related]
16. Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells. Noguchi H; Sakamoto C; Wada K; Akamatsu T; Uchida T; Tatsuguchi A; Matsui H; Fukui H; Fujimori T; Kasuga M Gastroenterology; 1999 Nov; 117(5):1119-27. PubMed ID: 10535875 [TBL] [Abstract][Full Text] [Related]
17. Expression of heregulin by mouse mammary tumor cells: role in activation of ErbB receptors. Schmitt M; Walker MP; Richards RG; Bocchinfuso WP; Fukuda T; Medina D; Kittrell FS; Korach KS; DiAugustine RP Mol Carcinog; 2006 Jul; 45(7):490-505. PubMed ID: 16482517 [TBL] [Abstract][Full Text] [Related]
18. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway. St-Laurent V; Sanchez M; Charbonneau C; Tremblay A J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):23-37. PubMed ID: 15862947 [TBL] [Abstract][Full Text] [Related]
19. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis. Weinstein EJ; Leder P Cancer Res; 2000 Jul; 60(14):3856-61. PubMed ID: 10919660 [TBL] [Abstract][Full Text] [Related]
20. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling. Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]